acebutolol has been researched along with Recrudescence in 2 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanner, LA | 1 |
| Bosco, LA | 1 |
| Zimmerman, HJ | 1 |
| Vital Durand, M | 1 |
2 other studies available for acebutolol and Recrudescence
| Article | Year |
|---|---|
Hepatic toxicity after acebutolol therapy.
Topics: Acebutolol; Adult; Chemical and Drug Induced Liver Injury; Female; Humans; Liver Diseases; Liver Fun | 1989 |
[Recurrent anosmia under beta-blockers].
Topics: Acebutolol; Adrenergic beta-Antagonists; Humans; Male; Middle Aged; Olfaction Disorders; Recurrence | 1985 |